Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local ischemic preconditioning improves skeletal muscle blood flow and vasodilation during exercise in older adults.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Response.

Medicine and science in sports and exercise·2026
Same author

The impact of biological sex and female sex hormone concentration on the maximal metabolic steady state.

Journal of applied physiology (Bethesda, Md. : 1985)·2025
Same author

Optimizing cerebrovascular endothelial health through shear stress modulation.

Experimental physiology·2025
Same author

Reliability and Repeatability of Determining Power Associated with Maximal Metabolic Steady State Using Changes in NIRS-Derived Muscle Oxygenation.

Medicine and science in sports and exercise·2025
Same author

The effects of menstrual cycle phase on acute critical power testing performance in healthy females.

European journal of applied physiology·2025

Related Experiment Video

Updated: Jun 21, 2026

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise.

Darren P Casey1, Brandon D Madery, Tasha L Pike

  • 1Department of Anesthesiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA. casey.darren@mayo.edu

Journal of Applied Physiology (Bethesda, Md. : 1985)
|August 8, 2009
PubMed
Summary

Adenosine does not appear to be essential for increased blood flow to skeletal muscles during exercise in low oxygen conditions. This study found that blocking adenosine receptors did not alter vasodilation during hypoxic exercise.

More Related Videos

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Area of Science:

  • Exercise Physiology
  • Cardiovascular Physiology
  • Human Physiology

Background:

  • Hypoxic exercise, characterized by reduced oxygen availability, can lead to significant changes in skeletal muscle blood flow.
  • Adenosine is a known vasodilator, and its role in exercise-induced vasodilation, particularly under hypoxic conditions, requires further clarification.

Purpose of the Study:

  • To investigate the role of adenosine in mediating augmented skeletal muscle vasodilation during hypoxic exercise in humans.
  • To determine if blocking adenosine receptors affects forearm vascular conductance during exercise under normoxia and hypoxia.

Main Methods:

  • Subjects performed incremental forearm exercise at 10% and 20% of maximum intensity under normoxic and normocapnic hypoxic conditions (80% arterial O2 saturation).
  • Intra-arterial administration of aminophylline (adenosine receptor antagonist) and phentolamine (alpha-adrenoceptor antagonist) was used in separate protocols.
  • Forearm vascular conductance (FVC) was calculated from forearm blood flow and mean arterial blood pressure.

Main Results:

  • Aminophylline administration did not alter the augmented forearm vascular conductance (DeltaFVC) during hypoxic exercise at either intensity.
  • Phentolamine administration also did not affect DeltaFVC during hypoxic exercise.
  • Combined phentolamine and aminophylline administration did not significantly change DeltaFVC compared to phentolamine alone.
  • However, aminophylline administration did reduce the vasodilation response to exogenous adenosine, confirming its efficacy as an antagonist.

Conclusions:

  • Adenosine receptor activation is not obligatory for the augmented vasodilation observed in skeletal muscle during hypoxic exercise in humans.
  • These findings suggest that other mechanisms, independent of adenosine, are primarily responsible for the increased blood flow during this type of exercise.